RCT for Pregabalin in Restless Legs Syndrome in South Korea

Summary

This randomized, double-blind, placebo-controlled, multicenter clinical trial is designed to to assess the treatment efficacy and tolerability of pregabalin in patients with idiopathic restless legs syndrome in South Korea.

Timeline

Start

2020-02-24

Primary completion

2022-04-04

Completion

2022-04-04

Publications

• Sunwoo JS, Cho YW, Shin WC, Byun JI, Shin JW, Jung KY. Efficacy and Safety of Pregabalin for Restless Legs Syndrome in Korean Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Neurol. 2025 Jul;21(4):325-331. doi: 10.3988/jcn.2025.0092.

Drugs

Indications